Carregant...
Identification of Monotonically Differentially Expressed Genes for IFN-β-Treated Multiple Sclerosis Patients
Multiple sclerosis (MS) is a common neurological disability of the central nervous system. Immune-modulatory therapy with interferon-β (IFN-β) has been used as a first-line treatment to prevent relapses in MS patients. While the therapeutic mechanism of IFN-β has not been fully elucidated, the data...
Guardat en:
| Publicat a: | Biomed Res Int |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Hindawi
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6930778/ https://ncbi.nlm.nih.gov/pubmed/31915697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/5647902 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|